EP3250208
7-bensýl-4-(4-(tríflúrmetýl)bensýl)-1,2,6,7,8,9-hexahýdróimídasó[1,2-A]pýrídó[3,4-E]pýrímídín-5(4H)-ón og sölt þar af og notkun þeirra í meðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.1.2016EP published:
30.9.2020EP application number:
16744237.5
EP translation filed:
22.12.2020Grant published:
15.1.2021EPO information:
European Patent Register
Max expiry date:
28.1.2036Expiry date:
28.1.2027Next due date:
31.1.2027
Title:
7-BENZYL-4-(4-(TRIFLUOROMETHYL)BENZYL)-1,2,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(4H)-ONE AND SALTS THEREOF AND THEIR USE IN THERAPY
Timeline
Today
29.1.2016EP application
30.9.2020EP Publication
22.12.2020Translation submitted
15.1.2021Registration published
28.1.2027Expires
Owner
Name:
Oncoceutics, Inc.Address:
3675 Market Street Suite 200, Philadelphia, PA 19104, US
Inventor
Name:
STOGNIEW, MartinAddress:
Florida 34202, US
Name:
ALLEN, Joshua E.Address:
New Haven, Connecticut 06511, US
Name:
POTTORF, Richard S.Address:
Indianapolis, Indiana 46526, US
Name:
NALLAGANCHU, Bhaskara RaoAddress:
Hillsborough, New Jersey 08852, US
Name:
OLSON, Gary L.Address:
Mountainside, New Jersey 07092, US
Name:
SUN, YanjunAddress:
Kendall Park, New Jersey 08824, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201562109737 PDate:
30.1.2015Country:
US
Number:
201562148844 PDate:
17.4.2015Country:
US
Number:
201562233757 PDate:
28.9.2015Country:
US
Classification
Categories:
A61K 31/519, C07D 471/12
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 19.1.2021
Expires: 28.1.2022
Payer: Patice ehf.
Number: 7
Paid: 31.12.2021
Expires: 28.1.2023
Payer: Patice ehf.
Number: 8
Paid: 3.1.2023
Expires: 28.1.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 4.1.2024
Expires: 28.1.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.1.2025
Expires: 28.1.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 20.1.2026
Expires: 28.1.2027
Payer: Árnason Faktor ehf.